In this last episode of the 6-part series, an expert describes what is known about the SARS-CoV-2 variants—including the UK, South African, and Brazilian variants that are becoming more prevalent in the United States. The discussion then focuses on how these variants impact the efficacy of vaccines and monoclonal antibodies. Claim your credit at pce.is/COV19.
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the emerging SARS-CoV-2 variants impact our COVID-19 toolbox.In this last episode of the 6-part series, an expert describes what is known about the SARS-CoV-2 variants—including the UK, South African, and Brazilian variants that are becoming more prevalent in the United States. The discussion then focuses on how these variants impact the efficacy of vaccines and monoclonal antibodies. Claim your credit at pce.is/COV19.